お知らせ • Apr 17
GMH Spa acquired 31.69% stake in OPS Retail S.p.A. (BIT:OPR) from VDB Srl for €0.18 million. GMH Spa acquired 31.69% stake in OPS Retail S.p.A. (BIT:OPR) from VDB Srl for €0.18 million on April 16, 2026. The transaction involved a total of 20.3 million shares, transferred at a price of €0.009 each, for a total value of €0.2 million. Following the transaction VDB Srl no longer hold any stake in OPS Retail.
GMH Spa completed the acquisition of 31.69% stake in OPS Retail S.p.A. (BIT:OPR) from VDB Srl on April 16, 2026. お知らせ • Oct 31
Netweek S.p.A., Annual General Meeting, Dec 01, 2025 Netweek S.p.A., Annual General Meeting, Dec 01, 2025, at 09:30 W. Europe Standard Time. New Risk • Oct 11
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 14% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (2,267% average daily change). Earnings have declined by 28% per year over the past 5 years. Market cap is less than US$10m (€1.19m market cap, or US$1.31m). Minor Risk Shareholders have been diluted in the past year (14% increase in shares outstanding). Buy Or Sell Opportunity • Sep 24
Now 88% undervalued after recent price drop Over the last 90 days, the stock has fallen 98% to €0.0002. The fair value is estimated to be €0.0017, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.8% over the last 3 years. Earnings per share has declined by 13%. New Risk • Sep 16
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (1,680% average daily change). Market cap is less than US$10m (€1.11m market cap, or US$1.23m). Minor Risk Shareholders have been diluted in the past year (3.0% increase in shares outstanding). Buy Or Sell Opportunity • Sep 09
Now 88% undervalued after recent price drop Over the last 90 days, the stock has fallen 99% to €0.0002. The fair value is estimated to be €0.0017, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.8% over the last 3 years. Earnings per share has declined by 13%. Buy Or Sell Opportunity • Aug 09
Now 87% undervalued after recent price drop Over the last 90 days, the stock has fallen 99% to €0.0002. The fair value is estimated to be €0.0015, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.8% over the last 3 years. Earnings per share has declined by 13%. Buy Or Sell Opportunity • Jul 10
Now 84% undervalued after recent price drop Over the last 90 days, the stock has fallen 99% to €0.0002. The fair value is estimated to be €0.0013, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.8% over the last 3 years. Earnings per share has declined by 13%. Buy Or Sell Opportunity • Jul 01
Now 84% undervalued after recent price drop Over the last 90 days, the stock has fallen 68% to €0.011. The fair value is estimated to be €0.071, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.8% over the last 3 years. Earnings per share has declined by 13%. Buy Or Sell Opportunity • Jun 19
Now 82% undervalued after recent price drop Over the last 90 days, the stock has fallen 90% to €0.0038. The fair value is estimated to be €0.021, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.8% over the last 3 years. Earnings per share has declined by 13%. New Risk • May 23
New major risk - Revenue and earnings growth Earnings have declined by 2.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (62% average daily change). Earnings have declined by 2.8% per year over the past 5 years. Market cap is less than US$10m (€2.52m market cap, or US$2.73m). Minor Risk Shareholders have been diluted in the past year (3.5% increase in shares outstanding). New Risk • Apr 16
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (50% average daily change). Shareholders have been substantially diluted in the past year (245% increase in shares outstanding). Market cap is less than US$10m (€2.77m market cap, or US$2.94m). Minor Risk Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). New Risk • Nov 02
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.13m (US$9.64m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€32m free cash flow). Share price has been highly volatile over the past 3 months (9.2% average weekly change). Shareholders have been substantially diluted in the past year (238% increase in shares outstanding). Market cap is less than US$10m (€9.13m market cap, or US$9.64m). New Risk • Jun 30
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 233% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (23% average weekly change). Negative equity (-€6.6m). Shareholders have been substantially diluted in the past year (233% increase in shares outstanding). Minor Risk Market cap is less than US$100m (€16.8m market cap, or US$18.2m). お知らせ • Jun 09
Netweek S.p.A. announced that it expects to receive €5 million in funding Netweek S.p.A. announced a private placement of convertible bonds and warrants for the gross proceeds of €5 million on June 8, 2023. Board Change • Nov 16
Less than half of directors are independent There are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. 3 experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). President of the Board & CEO Alessio Laurenzano is the most experienced director on the board, commencing their role in 2014. Independent Director Pasquale Lionetti was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Reported Earnings • Oct 05
First half 2022 earnings released: EPS: €0 (vs €0.009 loss in 1H 2021) First half 2022 results: EPS: €0. Revenue: €11.4m (flat on 1H 2021). Net loss: €1.36m (loss widened 12% from 1H 2021). Board Change • Apr 27
Less than half of directors are independent There are 6 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 6 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). President of the Board & CEO Alessio Laurenzano is the most experienced director on the board, commencing their role in 2014. Independent Director Pasquale Lionetti was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Jun 04
Full year 2020 earnings released: €0.015 loss per share (vs €0.037 loss in FY 2019) The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: €23.3m (down 11% from FY 2019). Net loss: €2.02m (loss narrowed 58% from FY 2019).